Suggestions
Maria Antonakos
Founder and Chief Operating Officer at Allarta Life Science Inc.
Maria Antonakos is the Founder and Chief Operating Officer of Allarta Life Science Inc., a company focused on developing innovative cell therapies, particularly for Type 1 Diabetes (T1D). She co-founded Allarta in 2019 alongside Dr. Harald Stover, leveraging her extensive background in business and commitment to diversity and inclusion within the scientific community.
Education and Early Career
Maria holds an MBA from the DeGroote School of Business at McMaster University and a Bachelor of Arts in Music from the University of Toronto. Before establishing Allarta, she spent eight years at the Perimeter Institute for Theoretical Physics, where she gained significant experience in corporate strategy and business development. Additionally, she has held senior roles at prominent organizations such as Roy Thomson Hall and the Canadian Women’s Foundation, where she initiated programs aimed at empowering women in various fields, including STEM.125
Role at Allarta Life Science
As COO, Maria leads Allarta's corporate strategy and business development efforts. The company is recognized for its proprietary platform technology that aims to deliver curative cell and stem cell therapies while overcoming challenges such as immune rejection. Under her leadership, Allarta has developed a hydrogel technology designed to protect transplanted cells from immune responses, which is critical for advancing treatments for T1D.134
Advocacy and Community Engagement
Maria is also actively involved in community service as a board member of the Leacross Foundation, which focuses on promoting economic independence for women and children through STEM training initiatives. Her work emphasizes her dedication to fostering inclusive environments within both corporate and community settings.15
In summary, Maria Antonakos combines her expertise in business with a passion for innovation and social equity to drive advancements in life sciences through Allarta Life Science Inc.
Highlights


